Lotus Pharmaceutical Co Ltd
TWSE:1795

Watchlist Manager
Lotus Pharmaceutical Co Ltd Logo
Lotus Pharmaceutical Co Ltd
TWSE:1795
Watchlist
Price: 282 TWD 0.18% Market Closed
Market Cap: 74.8B TWD
Have any thoughts about
Lotus Pharmaceutical Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

14.2
Current
13.1
Median
13.7
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
14.2
=
Enterprise Value
81.7B TWD
/
EBITDA
5.8B TWD
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
10.4
2-Years Forward
EV/EBITDA
7.9
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More